Example: Heart Attack

Clinical Trials on Neoplasms, Squamous Cell

Total 2385 results

NCT01075841

Withdrawn

A Post-marketing Surveillance Study on Erbitux in Combination With Platinum-based Chemotherapy in Metastatic/Recurrent Squamous Cell Cancer of the Head and Neck

Conditions: Neoplasms, Squamous Cell
NCT00229723

Completed

IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma

Conditions: Neoplasms, Squamous Cell
NCT01709448

Unknown status

Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV

Conditions: Neoplasms, Squamous Cell; Papillomavirus Infections
NCT01741727

Completed

A Study of ABT-414 in Subjects With Solid Tumors

Conditions: Squamous Cell Tumors
NCT03183115

Recruiting

RFA to Prevent Metachronous Squamous Neoplasia Recurrence After Complete Endoscopic Submucosal Dissection

Conditions: Esophageal Squamous Cell Neoplasm
NCT03937791

Completed

Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions

Conditions: Squamous Lntraepithelial Lesions of Vulva; Neoplasms, Squamous Cell; Vulvar HSIL
NCT02268747

Unknown status

Efficacy and Safety of Dacomitinib in the Treatment of Skin Squamous Cell Cancer

Conditions: Skin Squamous Cell Cancer
NCT01075828

Completed

Prospective, Post Marketing Surveillance Study On Erbitux® (Cetuximab) in Patients With Locally Advanced or Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck in Korea

Conditions: Head and Neck Cancer
NCT02784288

Active, not recruiting

Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer

Conditions: Oropharyngeal Squamous Cell Cancer
NCT03138070

Recruiting

A Window of Opportunity Study to Assess the Modulation of Biomarkers in Head and Neck Squamous Cell Cancer (HNSCC) By Preoperative Treatment With BYL719

Conditions: Head and Neck Squamous Cell Cancer
NCT02485548

Unknown status

Cisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell Cancer

Conditions: Head and Neck Squamous Cell Cancer
NCT02282371

Active, not recruiting

Cetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell Cancer (HNSCC)

Conditions: Head and Neck Squamous Cell Cancer
NCT01914900

Completed

Preoperative TPF Chemotherapy in a Population of Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer

Conditions: Locally Advanced Resectable Oral Cavity Squamous Cell Cancer
NCT02083692

Completed

Pilot Study of Metformin in Head and Neck Squamous Cell Cancer and Its Effects on Stromal-epithelial Metabolic Uncoupling

Conditions: Head and Neck Squamous Cell Cancer
NCT00530283

Completed

PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary Malignancy

Conditions: Squamous Cell Cancer
NCT03667482

Recruiting

Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer

Conditions: Head and Neck Squamous Cell Cancer; Recurrent Head and Neck Squamous Cell Cancer; Metastatic Head and Neck Squamous Cell Cancer
NCT01326923

Terminated

Induction Chemo Then Concurrent Chemoradiotherapy With Cetuximab in Locally Advanced Head and Neck Squamous Cell Cancer

Conditions: Head and Neck Squamous Cell Cancer
NCT01721525

Completed

Induction Chemotherapy With Afatinib, Ribavirin, and Weekly Carboplatin/Paclitaxel for Stage IVA/IVB HPV Associated Oropharynx Squamous Cell Cancer (OPSCC)

Conditions: Head and Neck Cancer; Squamous Cell Cancer
NCT01016769

Completed

Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)

Conditions: Squamous Cell Cancer; Head and Neck Cancer
NCT00661427

Completed

Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer

Conditions: Head and Neck; Squamous Cell Cancer
NCT00815295

Completed

Study of Sorafenib/Cetuximab in Head and Neck Cancer

Conditions: Squamous Cell Cancer
NCT00705016

Completed

Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Conditions: Squamous Cell Cancer
NCT00768664

Completed

Open-Label Trial Of Oral PF-00299804 By Continuous Dosing In Patients With Recurrent Or Metastatic Head And Neck Squamous Cell Cancer

Conditions: Head and Neck Neoplasms
NCT02842125

Terminated

Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer

Conditions: Metastatic Solid Tumor Cancer; Recurrent Head and Neck Cancer
NCT01183065

Completed

Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)

Conditions: Head and Neck Cancer